10.0.1.239

Vatera Healthcare Partners leads $67.5m investment in Rib-X Pharmaceuticals

1071
Biopharmaceutical company Rib-X Pharmaceuticals has closed the first tranche of a $67.5m Series 2 preferred stock financ